ANGOANGIODYNAMICS INC
Surgical & Medical Instruments & Apparatus
- Revenue
- $320M
- 9.5% YoY
- Operating margin
- -12.5%
- 8.7% YoY
- EBITDA
- −$17M
- 20% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- —
- −$34M net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear—Cash flow under 80% of net income
- Dilutive SBCClear4% of revenueOver 10% of revenue
- Payouts exceed cash flowClear0% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear0% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $316M | $339M | $304M | $292M | $320M | 9.5% |
| Operating income | −$28M | −$51M | −$192M | −$40M | −$40M | 0.1% |
| Net income | −$27M | −$52M | −$184M | −$34M | −$37M | 8.1% |
| Operating cash flow | −$7M | $78K | −$28M | −$10M | $3M | 130% |
| Capex | $4M | $4M | $3M | $4M | $3M | 42% |
| Stock-based comp | $11M | $11M | $11M | $10M | $14M | 43% |
| Buybacks | — | $0 | $0 | $2M | $0 | 100% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $311K · 2
- Net
- −$311K
Pay vs performance
| Year | CEO total comp | Comp actually paid | TSR (indexed) | Peer TSR |
|---|---|---|---|---|
| FY2026 | $6M | $14M | 50 | 57 |
| FY2025 | $5M | $7M | 44 | 43 |
| FY2024 | $5M | $971K | 27 | 43 |
| FY2023 | $4M | −$2M | 41 | 56 |
| FY2022 | $6M | $5M | 85 | 59 |